Consequently, understanding the interplay between MIF protein levels, genetic variations, and the formation of MIF-CXCL4L1 heterocomplexes is crucial for deciphering the multifaceted molecular mechanisms underlying CAD and devising targeted therapeutic strategies aimed at disrupting these detrimental interactions (50). This evidence concerns the gene MIF and coronary artery disorder.